Quantcast

Latest Oncology Stories

2014-08-12 12:26:10

1,000 San Diegans Expected for Jazzercise Dance for Life Fundraiser to Support Susan G. Komen CARLSBAD, Calif., Aug. 12, 2014 /PRNewswire/ -- Jazzercise instructors will bring San Diegans together to fight breast cancer and dance for a cure aboard the USS Midway on Saturday, September 13(th), from 8:30 to 10 a.m. An estimated 1,000 Jazzercise instructors, customers, family and friends, including many who have been affected by breast cancer, will participate in a huge group fitness...

2014-08-12 11:57:56

Wiley A new analysis confirms that US lung cancer rates are declining overall, but it also uncovers previously unrecognized trends related to cancer subtype, sex, race/ethnicity, and age. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings provide a more accurate picture of the state of lung cancer in the country and will help researchers in their ongoing efforts to monitor the population's lung health. Overall, lung cancer rates are...

2014-08-12 08:31:32

Innovative OncoSolutions to Distribute Leading Closed System Transfer Devices in Canada; Announcement Comes Shortly After FDA Clears Device under ONB Product Code PORT WASHINGTON, New York and OAKVILLE, Ontario, August 12, 2014 /PRNewswire/ -- Equashield (http://www.equashield.com), a leading provider of Closed System Transfer Device [http://www.equashield.com ]s (CSTDs) for hazardous drugs, announced today a new exclusive partnership with Canadian distributor Innovative...

2014-08-12 08:29:40

IRVING, Texas, Aug. 12, 2014 /PRNewswire/ -- Doctors at the LSU Health Shreveport Feist-Weiller Cancer Center will now have access to innovative, precision-medicine technology that determines the unique biological characteristics of each individual patient's cancer tumor. Once that information is known, physicians can identify tailored chemotherapy or radiation regimens to attack it. The new capability is the result of emerging technology called tumor profiling. Feist-Weiller will...

2014-08-11 23:07:52

The Mesothelioma Victims Center stands well above other mesothelioma advocates in the nation when it comes to diagnosed victims getting the best possible financial compensation by making certain every single victim is connected to one of the nation's most skilled compensation attorneys and has the most up-to-date information on the best possible medical treatment(s). As the Center would like to explain with one call to 866-714-6466, diagnosed victims who live in California have the...

2014-08-11 23:02:23

The Firm is seeking to hear from women who allegedly experienced the spread of uterine sarcoma and other gynecological cancers due to uterine morcellation. New York, New York (PRWEB) August 11, 2014 As the controversy surrounding the use of power morcellators (http://www.injurybeacon.com/power-morcellator/) continues to grow, Bernstein Liebhard LLP notes that nearly a year has passed since a pair of doctors first launched their campaign to ban uterine morcellation. In an interview that...

2014-08-11 12:29:17

HINGHAM, Mass., Aug. 11, 2014 /PRNewswire/ -- WHO: Talbots/National Breast Cancer Foundation WHAT: During the Month of October, Talbots will sell two items in support of Breast Cancer Awareness. Talbots will donate 100% of the net proceeds from the sale of a limited- edition T-Shirt and Tote Bag to the...

2014-08-11 08:29:37

WASHINGTON, Aug. 11, 2014 /PRNewswire/ -- The New York Mesothelioma Victims Center is strongly encouraging diagnosed victims in New York State to call them at 866-714-6466, before they retain the services of an attorney to advance a mesothelioma compensation claim, because as they would like to explain the best attorneys get much better compensation results for their clients. In this instance the Center is specifically talking about diagnosed victims, or their family members losing...

2014-08-11 08:29:18

Trial Progressing On Track; BETHESDA, Md., Aug. 11, 2014 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced an update about the Company's Phase III clinical trial of DCVax®-L for Glioblastoma multiforme (GBM) brain cancer in conjunction with the Company's separate announcement today about certain changes to the Phase III trial. The update from the Company...

2014-08-11 08:28:56

SAN DIEGO, Aug. 11, 2014 /PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX) today announced that the U.S. FDA has granted Orphan Drug Designation to mocetinostat, a spectrum selective HDAC inhibitor, for diffuse large B-cell lymphoma (DLBCL). In June, mocetinostat was granted Orphan Drug Designation as a treatment for myelodysplastic syndrome (MDS). Orphan drug designation is also being sought for bladder cancer patients with specific genetic alterations. Mocetinostat is being...


Word of the Day
cenobite
  • One of a religious order living in a convent or in community; a monk: opposed to anchoret or hermit (one who lives in solitude).
  • A social bee.
This word comes from the Latin 'coenobium,' convent, which comes from the Greek 'koinobios,' living in community.
Related